|
RARE The RARE Diseases Business Unit, the latest addition to Chiesi's portfolio, is dedicated to providing advanced treatments for individuals living with rare or ultra - rare genetic diseases. It ...
Adnkronos
-
22-4-2024
|
|
|
|
... analysis of genetic and epigenetic determinants (DIT. AD010.039) Abstract The development of genome editing makes it easier to intervene in a targeted manner on genes to either modify their product ...
CNR
-
18-4-2024
|
|
|
|
Ey advisory va ad aggiungersi a un portafoglio italiano di di Cvc, che vede tra gli asset di maggiore spicco gruppi come Recordati, Genetic, Multiversity e Piadineria. L'articolo Cvc Capital tratta l'...
The Insider
-
17-4-2024
|
|
|
|
Modalis is the pioneer and leader in CRISPR - based epigenome modulation technology, developing therapeutics for patients suffering from serious genetic disorders such as neuromuscular diseases, CNS, ...
01Net
-
12-4-2024
|
|
|
|
LISSES, France-(BUSINESS WIRE)- #NBS - Sebia , a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders ...
01Net
-
5-4-2024
|
|
|
|
'Germline genetic sequencing allows us to determine an individual's risk of developing cancer and whether this risk has been inherited in their family members.' 'This comprehensive sequencing data ...
01Net
-
4-4-2024
|
|
|
|
About Tianlong Tianlong is an innovative high - tech company specializing in genetic detection and molecular diagnostic products in China. Since its foundation in 1997, Tianlong has devoted itself to ...
Adnkronos
-
3-4-2024
|
|
|
|
... MD, Dana Farber Cancer Institute In this study, whole exome and whole transcriptome sequencing was utilized to evaluate the impact of HIV status and Epstein - Barr Virus (EBV) on the genetic ...
01Net
-
2-4-2024
|
|
|
|
L'esperimento è stato condotto presso il Department of Twin Research & Genetic Epidemiology del King's College di Londra, ed è durato 12 settimane, come riporta il sito Tech.everyeye.it: Hugo ha ...
superEva
-
29-1-2023
|
|
|
|
Uno studio condotto da un gruppo di ricercatori dell'Università di Trieste, del King's College of London e dell'International Centre for Genetic Engineering and Biotechnology (ICGEB) di Trieste, e pubblicato sul Journal of Pathology , ha rivelato nuovi aspetti dell'infezione da Covid e dei danni ai polmoni causati dal virus Sars - Cov -...
QuiFinanza
-
22-1-2023
|
|
|
